| HOME >> MEDICINE >> TECHNOLOGY |
Table 76: Ovarian Cancer Therapeutics Market, Spain, Treatment Usage Patterns, 2011–2020 184
Table 77: Ovarian Cancer Therapeutics Market, Spain, Drug Sales ($m), 2002–2011 187
Table 78: Ovarian Cancer Therapeutics Market, Spain, Drug Sales ($m), 2011–2020 188
Table 79: Ovarian Cancer Therapeutics Market, Japan, Drug Sales ($m), 2002-2011 190
Table 80: Ovarian Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2002–2011 192
Table 81: Ovarian Cancer Therapeutics Market, Japan, Patient Volume, 2002–2011 194
Table 82: Ovarian Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 2002–2011 196
Table 83: Ovarian Cancer Therapeutics Market, Japan, Sales Value ($m), 2011–2020 201
Table 84: Ovarian Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2011–2020 203
Table 85: Ovarian Cancer Therapeutics Market, Japan, Patient Volume, 2011–2020 205
Table 86: Ovarian Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 2011–2020 207
Table 87: Ovarian Cancer Therapeutics Market, Japan, Drug Sales ($m), 2002–2011 210
Table 88: Ovarian Cancer Therapeutics Market, Japan, Drug Sales ($m), 2011–2020 211
Table 89: Ovarian Cancer Therapeutics Market, Brazil, Sales Value ($m), 2002–2011 213
Table 90: Ovarian Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 2002–2011 215
Table 91: Ovarian Cancer Therapeutics Market, Brazil, Patient Volume, 2002–2011 216
Table 92: Ovarian Cancer Therapeutics Market, Brazil, Treatment Usage Patterns, 2002–2011 218
Table 93: Ovarian Cancer Therapeutics Market, Brazil, Sales Value ($m), 2011–2020 223
Table 94: Ovarian Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 2011–2020
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |